Reckitt Announces US FDA Approval Of Mucinex® 12hr Cold & Fever Multi-Symptom, The First OTC Innovation In The Cold & Flu Category In 14 Yea
Reckitt Announces US FDA Approval Of Mucinex® 12hr Cold & Fever Multi-Symptom, The First OTC Innovation In The Cold & Flu Category In 14 Years
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.